These data together with the fact that GPX4 deletion within PanINs was insufficient to trigger ferroptosis in pancreatic cancer [14], support the idea that KRAS-mutated cells have evolved an additional layer of protection against ferroptotic cell death. The gene discussed is GPX4; the disease is pancreatic neoplasm.